News
Reminder: CRI Abstract Deadline is March 14
The AACI CRI Steering Committee is currently soliciting abstracts for the 14th Annual AACI CRI Meeting. This year’s meeting theme will focus on innovation in cancer clinical research. The purpose of the abstracts is to inform meeting attendees about clinical trials office challenges and solutions implemented at AACI cancer centers.
Updates to the 2022 Submission Process
This year, AACI has increased the number of abstract submission categories to eight. The categories will be Regulatory; Quality Assurance, Remote Monitoring and Auditing; Finance/CCSG/PRMS; Trial Recruitment & Community Outreach and Engagement; Trial Start-up; Clinical Operations; Investigator-Initiated Trials; and Training and Career Development.
As in 2021, abstracts will be submitted online. The online submission tool opened in February. A style guide has been made available to help standardize the format of all abstracts to facilitate their review and publication for the annual CRI Abstracts and Posters Book.
Three abstracts will be selected for oral presentation at the meeting. Up to two authors of each winning abstract will receive a complimentary meeting registration or a refund for a previously paid meeting registration fee. While AACI encourages collaboration with external organizations, only employees of AACI member cancer centers are eligible for complimentary meeting registration. Additionally, AACI will recognize eight abstracts, one from each abstract category, to be presented at an honorable mention session.
Important Dates
March 14, 2022 | 5:00 PM PT
Deadline to submit abstracts
May 2022
Abstracts selected for oral presentation notifications sent to submitting authors
May 16, 2022 | 5:00 PM PT
Deadline to submit an electronic copy of your poster and/or a digital presentation to [email protected]